Association of serum alanine aminotransferase levels with cardiometabolic risk factors in normal-weight and overweight children

Iranian Journal of Pediatrics

Volumn 21, Issue 3, 2011, Pages 287-293

  Samani, Shohreh Ghatreh ^a   Kelishadi, Roya ^a,b   Adibi, Atoosa ^b   Noori, Hengameh ^a   Moeini, Mina ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiometabolic risk factors; Children; Fatty liver; Prevention

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK FACTOR; CARDIOVASCULAR RISK; CHILD; CHILD HEALTH; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART MUSCLE METABOLISM; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

EID: 80052880097     PISSN: 10184406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008;134(6):1682-1698.
2. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev 2007;29: 62-76.
3. Kelishadi R, Ardalan G, Gheiratmand R, et al. CASPIAN Study Group: Association of physical activity and dietary behaviours in relation to the body mass index in a national sample of Iranian children and adolescents: CASPIAN Study. Bull World Health Organ 2007;85(1):19-26.
4. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004;328(7446):983.
5. Burgert TS, Taksali SE, Dziura J, et al. Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006;91(11):4287-4294.
6. Schindhelm RK, Diamant M, Bakker SJ, et al. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. Eur J Clin Invest 2005;35(6):369-374.
7. Musso G, Gambino R, Bo S, et al. should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in non obese non diabetic subjects. Diabetes Care 2008;31(3):562-568.
8. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999;107(5): 450-455.
9. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-1847.
10. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol 2007;102(12):2708-2715.
11. Duman DG, Celikel C, Tüney D, et al. Computed tomography in nonalcoholic fatty liver disease: a useful tool for hepatosteatosis assessment? Dig Dis Sci 2006;51(2):346-351.
12. Sattar N, Scherbakova O, Ford I, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. Diabetes 2004;53(11):2855-2860.
13. Vozarova B, Stefan N, Lindsay RS, et al. High alanine amino transferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002;51(6):1889-1895.
14. Oh SY, Cho YK, Kang MS, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006;55(12): 1604-1609.
15. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine. aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr 2005;82(5): 1046-1051.
16. Lee SW, Park SH, Kim KW, et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007;244(2):479-485.
17. Fishbein MH, Gardner KG, Potter CJ, et al. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 1997;15(3):287-293.
18. Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006;6:33.
19. Mofrad P, Contos MJ, Haque M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003;37(6):1286-1292.
20. Oliveira AM, Oliveira N, Reis JC, et al. Triglycerides and alanine aminotransferase as screening markers for suspected fatty liver disease in obese children and adolescents. Horm Res 2009;71(2):83-88.
21. Jagarinec N, Flegar-Mestrić Z, Surina B, et al. Pediatric reference intervals for 34 biochemical analyses in urban school children and adolescents. Clin Chem Lab Med 1998;36(5):327-337.
22. Burritt MF, Slockbower JM, Forsman RW, et al. Mayo Clin Proc. Pediatric reference intervals for 19 biologic variables in healthy children. 1990; 65(3):329-336.
23. Di Bonito P, Sanguigno E, Di Fraia T et al. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism 2009; 58(3):368-372.
24. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137(1):1-10.
25. Kelishadi R, Cook SR, Adibi A, et al. Association of the components of the metabolic syndrome with non-alcoholic fatty liver disease among normal- weight, overweight and obese children and adolescents. Diabetol Metab Syndr 2009; 1:29.
26. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM. CDC growth charts: United States. Adv Data. 2000, 314:1-27.
27. De Ferranti SD, Gauvreau K, Ludwig DS, et al. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110(16):2494-2497.
28. Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R; Caspian Study Group. Paediatric metabolic syndrome and associated anthropometric indices: the CASPIAN Study. Acta Paediatr. 2006;95(12):1625-34.
29. Yoo J, Lee S, Kim K, et al. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children. Diabetes Res Clin Pract 2008;81(3):321-326.
30. Esmaillzadeh A, Mirmiran P, Azizi F. Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr 2006;83(1):36-46.
31. Alavian SM, Motlagh ME, Ardalan G, et al. Hypertriglyceridemic waist phenotype and associated lifestyle factors in a national population of youths: CASPIAN Study. J Trop Pediatr 2008;54(3):169-177.
32. Després JP, Cartier A, Côté M, Arsenault BJ. The concept of cardiometabolic risk: Bridging the fields of diabetology and cardiology. Ann Med 2008;40(7):514-523.
33. Mager DR, Patterson C, So S, et al. Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr 2010;64(6):628-635.
34. Hosseini S, Mousavi S, Poursafa P, et al. Risk Score Model for Predicting Sonographic Nonalcoholic Fatty Liver Disease in Children and Adolescents. Iran J Pediatr 2011;21(2):181-187.
35. Motlagh ME, Kelishadi R, Amirkhani MA, et al. Double burden of nutritional disorders in young Iranian children: findings of a nationwide screening survey. Public Health Nutr 2011;14(4): 605-610.
36. Kelishadi R, Ziaee V, Ardalan G. A National Experience on Physical Activity Initiatives for Adolescent Girls and Their Mothers: CASPIAN Study. Iran J Pediatr 2010;20(4):420-426.